Clinical Trial Update: Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 study comparing once-daily versus twice-daily dosing of insulin detemir in individuals with Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED